Vesele
Vesele, licence 80080616: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Vaso-XL
- Licence holder
- Innovus Pharmaceuticals, Inc.
- NPN or DIN-HM
- 80080616
- Status
- Inactive licence
- Licence date
- 13 October 2017
- Revision date
- 17 August 2022
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-Citrulline Source : Malate de citrulline | 283.24 mg | Not calculated |
| L-arginine Source : Monohydrochlorure de L-arginine | 250.0 mg | Not calculated |
| 1-[(2E, 4E)-5-(1,3-Benzodioxole-5-yl)-1-oxo-2,4-pentadiényl] pipéridine Source : Piper nigrum - fruit | 1.25 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Dioxyde de silicium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Workout supplement. Athletic support. Source of (an) amino acid(s) involved in muscle protein synthesis. L-Arginine supports production of nitric oxide, a molecule involved in vasodilation. L-Arginine supports nitric oxide production.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Ensure to drink enough fluid before, during, and after exercise. If you are pregnant or breastfeeding, consult a healthcare practitioner before using this product. If you are taking any other medications or natural health products, consult a health care practitioner prior to use, as black pepper/piperine may alter their effectiveness. Consult a health care practitioner prior to use if you have a renal/kidney disease or if you are following a low protein diet. Consult a health care practitioner prior to use if you suffer from a cardiovascular disease and are attempting an increase in physical activity. Consult your health care practitioner prior to use if you are taking medication for cardiovascular diseases, erectile dysfunction, and/or blood thinners. Consult a health care practitioner if your cardiovascular condition worsens.
Source
Official Health Canada record, licence 80080616
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.